Covering Diagnosis, Monitoring, and Emergency Treatment
Aiming to Become a Global Comprehensive Medical Device Company
CU Medical Systems (CEO Kim Hyungsoo) has signed an agreement to acquire shares and management rights of Vistos. CU Medical Systems expressed its ambition to create synergy with Vistos and grow into a global comprehensive medical device company.
According to the Financial Supervisory Service’s electronic disclosure system on the 27th, Vistos’s largest shareholder, Lee Hoojung, along with three others, signed a contract to transfer 7,789,160 shares (33.88%) to CU Medical Systems at 2,824 won per share, totaling 22 billion won.
This acquisition is a strategic investment by CU Medical Systems to move beyond its current focus on emergency medical devices and become an integrated medical device specialist covering diagnosis, monitoring, and treatment.
By securing Vistos’s Class 1 and 2 patient monitoring and biosignal monitoring technologies, CU Medical Systems plans to expand its existing product lineup, which is centered on Class 3 (defibrillators), into the lower-grade medical device market. Through this, the company will establish a complete product portfolio encompassing all medical device classes (Class 1 to 3).
Additionally, CU Medical Systems is considering expanding into animal medical devices and home healthcare product lines based on Vistos’s product technologies. This is expected to serve not only to diversify the medical device market but also as a bridgehead for entering the domestic and international B2C healthcare markets.
Vistos possesses a global distribution network spanning over 120 countries, including Latin America, the Middle East, and Asia. Through key certified products from global organizations such as the U.S. Food and Drug Administration (FDA)-including incubators, patient monitors, and home medical devices-the company has built strong trust in international markets.
CU Medical Systems plans to utilize Vistos’s certified product lineup and overseas network through this acquisition to expand into new markets in the United States, Europe, and the Middle East, and to pursue a joint brand strategy. This is also expected to strengthen the global export competitiveness of its AEDs (defibrillators) and emergency medical devices.
Furthermore, the two companies will integrate their research labs to unify overlapping personnel, equipment, and testing infrastructure, thereby establishing an integrated R&D system that enhances operational efficiency and research focus. They plan to strengthen collaboration at each stage of product development, aiming to simultaneously improve development speed and product quality.
In addition, CU Medical Systems will apply its own medical device manufacturing facilities and quality control know-how (QC system) to Vistos’s production lines to reduce manufacturing costs and maximize production efficiency. By introducing joint purchasing of components, standardization, and a joint quality verification system, the company aims to achieve economies of scale and enhance cost competitiveness.
A CU Medical Systems representative stated, "Through this acquisition, CU Medical Systems will secure a stable revenue structure and global growth momentum based on product and market diversification. The combination of Vistos’s technology and global infrastructure with CU Medical Systems’s manufacturing and operational expertise is expected to elevate our status as a global medical device specialist and increase our corporate value."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
